当前位置：
X-MOL 学术
›
Nat. Nanotechnol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
Nature Nanotechnology ( IF 38.1 ) Pub Date : 2017-05-01 00:00:00 , DOI: 10.1038/nnano.2017.69 Hengfeng Yuan , Wen Jiang , Christina A. von Roemeling , Yaqing Qie , Xiujie Liu , Yuanxin Chen , Yifan Wang , Robert E. Wharen , Kyuson Yun , Guojun Bu , Keith L. Knutson , Betty Y. S. Kim
Nature Nanotechnology ( IF 38.1 ) Pub Date : 2017-05-01 00:00:00 , DOI: 10.1038/nnano.2017.69 Hengfeng Yuan , Wen Jiang , Christina A. von Roemeling , Yaqing Qie , Xiujie Liu , Yuanxin Chen , Yifan Wang , Robert E. Wharen , Kyuson Yun , Guojun Bu , Keith L. Knutson , Betty Y. S. Kim
A multivalent bi-specific nanoconjugate can promote immune cells to recognize and eradicate cancer cells in a receptor targeted manner, leading to the generation of potent and durable anti-tumour immunity
中文翻译：
用于靶向癌症免疫治疗的多价双特异性纳米生物共轭物接合剂
多价双特异性纳米缀合物可以促进免疫细胞以受体靶向方式识别和根除癌细胞，从而导致产生强大而持久的抗肿瘤免疫力
更新日期：2017-05-18
中文翻译：
用于靶向癌症免疫治疗的多价双特异性纳米生物共轭物接合剂
多价双特异性纳米缀合物可以促进免疫细胞以受体靶向方式识别和根除癌细胞，从而导致产生强大而持久的抗肿瘤免疫力
京公网安备 11010802027423号